Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

HLS Therapeutics Inc T.HLS

Alternate Symbol(s):  HLTRF

HLS Therapeutics Inc. is a pharmaceutical company. It is focused on the acquisition and commercialization of late-stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets. It is engaged in addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease. It is also focused on products targeting the central nervous system and cardiovascular therapeutic areas. Its products include Clozaril, CSAN Pronto, MyCare Insite, MyCare Psychiatry, PERSERIS, Trinomia and Vascepa. Its lead product is Clozaril, which is an atypical antipsychotic indicated for the management of symptoms of treatment-resistant schizophrenia for the Canadian and United States markets. CSAN Pronto is a capillary point-of-care medical device designed to enhance and simplify the mandatory safety blood monitoring process for patients that are prescribed Clozaril. Trinomia product related to the treatment of cardiovascular disease.


TSX:HLS - Post by User

Bullboard Posts
Post by parkuson Mar 20, 2012 1:49pm
181 Views
Post# 19695504

Bottom In

Bottom In

I believe the bottom is in. Sentiment supports a bottom as do the technicals. This was a simple ABC correction with the C wave playing out in 5 waves.

A= $3.07-$2.19= $.88

B= $2.19-$2.87= $.68

C= $2.87-$2.09= $.78

C wave divides into the following:

1= $2.87-$2.51= $.36

2= $2.51-$2.74= $.23

3= $2.74-$2.20= $.54 (1.500 x wave 1)

4= $2.20-$2.44= $.24 (equals wave 2)

5= wave 1 @ $2.08. Today's low was $2.09

I would like to see a close above $2.20 today followed by a quick gap fill at $2.42 and $2.45. Alternative counts suggest a bottom at $2.03 or $1.99 but based on what I'm seeing now it looks like $2.09 was it. At $2.20 the stock is trading at a P/E of sub 4, only $.60 more than tangible book value, and is yielding 11%.

parkus

 

Bullboard Posts